Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0000899243-20-006629

Options or other derivatives

  • SVP, General Counsel acquired 197,889 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Manzano Stephen SVP, General Counsel 2020-02-27 Grant or award · Restricted Stock Units +65,963 65,963 D
Manzano Stephen SVP, General Counsel 2020-02-27 Grant or award · Performance-Based Restricted Stock Units +131,926 131,926 D
Loading xslF345X03/doc4.xml…